Female pattern hair loss (FPHL) as a distinctive entity was first described about 30 years ago. The objective of this study was to perform a systematic review of all randomized controlled trials for treatment of FPHL. A preliminary search was carried out in several databases up to August 2008 to identify all randomized controlled trials on nonsurgical interventions for treatment of FPHL. Studies reporting fewer than 10 patients and non-English articles were excluded. Additionally, references of relevant articles and reviews were checked manually in search for additional sources. Among 238 citations found in the preliminary search, 12 fulfilled all criteria to be included in the systematic review. Topical minoxidil 1 to 5 for 24 to 48 weeks ...
Androgenetic alopecia is a widespread problem in contemporary dermatology, as it may also affect man...
IntroductionCurrently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the F...
Lauren L Levy, Jason J Emer Department of Dermatology, Mount Sinai School of Medicine, New York, NY,...
Female pattern hair loss (FPHL) is the most common form of alopecia in women. Affected women may exp...
Abstract Female pattern hair loss (FPHL) is the most common hair loss in post-puberty female. Preval...
We describe a case of a 44-year-old woman with biopsy-proven female androgenic alopecia (FAGA), or f...
Background It has not been conclusively established that female pattern hair loss (FPHL) is either d...
Abstract: Fewer than 45 % of women go through life with a full head of hair. Female pattern hair los...
Background Female pattern hair loss (FPHL) is a distressing common problem. Minoxidil is the only FD...
Background: Androgenetic alopecia (AGA) occurs in both men and women. It is characterized by progres...
A critical appraisal and clinical application of Oliveira-Soares R, Silva JE, Correia M, André M. Fi...
Background and Objectives: Female pattern hair loss (FPHL) is a common form of scalp hair loss that ...
Oral minoxidil (OM) has been reported to be effective for androgenetic alopecia (AGA). In this retro...
BACKGROUND: There is no consensus on the standard treatment options for female pattern androgenetic...
Topical minoxidil has been used for many years as treatment for different hair disorders. Even thoug...
Androgenetic alopecia is a widespread problem in contemporary dermatology, as it may also affect man...
IntroductionCurrently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the F...
Lauren L Levy, Jason J Emer Department of Dermatology, Mount Sinai School of Medicine, New York, NY,...
Female pattern hair loss (FPHL) is the most common form of alopecia in women. Affected women may exp...
Abstract Female pattern hair loss (FPHL) is the most common hair loss in post-puberty female. Preval...
We describe a case of a 44-year-old woman with biopsy-proven female androgenic alopecia (FAGA), or f...
Background It has not been conclusively established that female pattern hair loss (FPHL) is either d...
Abstract: Fewer than 45 % of women go through life with a full head of hair. Female pattern hair los...
Background Female pattern hair loss (FPHL) is a distressing common problem. Minoxidil is the only FD...
Background: Androgenetic alopecia (AGA) occurs in both men and women. It is characterized by progres...
A critical appraisal and clinical application of Oliveira-Soares R, Silva JE, Correia M, André M. Fi...
Background and Objectives: Female pattern hair loss (FPHL) is a common form of scalp hair loss that ...
Oral minoxidil (OM) has been reported to be effective for androgenetic alopecia (AGA). In this retro...
BACKGROUND: There is no consensus on the standard treatment options for female pattern androgenetic...
Topical minoxidil has been used for many years as treatment for different hair disorders. Even thoug...
Androgenetic alopecia is a widespread problem in contemporary dermatology, as it may also affect man...
IntroductionCurrently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the F...
Lauren L Levy, Jason J Emer Department of Dermatology, Mount Sinai School of Medicine, New York, NY,...